Overview
Cassidy Bio has raised $8 million in seed funding, led by Ahren Innovation Capital, with participation from Lool Ventures and 10D VC, along with backing from AstraZeneca and Merck KGaA. The company aims to revolutionize gene-editing therapy development through its AI-driven genomic foundation model.
Products
Loading...
Recent Deals
Investors: Ahren Innovation Capital, Lool Ventures, 10D VC, AstraZeneca, Merck KGaA
Cassidy Bio has raised $8 million in seed funding, led by Ahren Innovation Capital, with participation from Lool Ventures and 10D VC, along with backing from AstraZeneca and Merck KGaA. The company aims to revolutionize gene-editing therapy development through its AI-driven genomic foundation model.